The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failure
- PMID: 36763124
- PMCID: PMC9998587
- DOI: 10.1007/s00134-023-06998-w
The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failure
Conflict of interest statement
Upon manuscript submission, all authors declare they have no competing interests.
Figures
Comment on
-
Similarities, Differences, and Potential Synergies in the Mechanism of Action of Albumin Dialysis Using the MARS Albumin Dialysis Device and the CytoSorb Hemoperfusion Device in the Treatment of Liver Failure.Blood Purif. 2021;50(1):119-128. doi: 10.1159/000508810. Epub 2020 Jul 2. Blood Purif. 2021. PMID: 32615564
-
Haemoadsorption by CytoSorb® in patients with acute liver failure: A case series.Int J Artif Organs. 2021 Aug;44(8):560-564. doi: 10.1177/0391398820981383. Epub 2020 Dec 10. Int J Artif Organs. 2021. PMID: 33302765
References
-
- Dominik A, Stange J. Similarities, differences, and potential synergies in the mechanism of action of albumin dialysis using the MARS albumin dialysis device and the CytoSorb hemoperfusion device in the treatment of liver failure. Blood Purif 2020; 1–10. - PubMed
-
- Tomescu D, et al. Haemoadsorption by CytoSorb(R) in patients with acute liver failure: A case series. Int J Artif Organs 2020; 391398820981383. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
